Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaier Granule in early-stage TNBC
NCT04790305Phase 4Recruiting
- Sponsor
- Fudan University
- Start
- Jun 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of huaier granule in triple-negative breast cancer (TNBC), sponsored by Fudan University. Started Jun 2021; status: recruiting.
02
Drugs
huaier granule
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT04790305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790305.